跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Lorasaph
Approved
STANDARD
Lorasaph
Sapphire Lifesciences Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a3b9243031a38889
Company
Sapphire Lifesciences Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
a3b9243031a38889
Drug Approval Philippines Name
Lorasaph
Product Name
Lorasaph
Registration Number
DRP-9611
Brand Name
Lorasaph
Generic Name
Loratadine
Dosage Form
Tablet
Dosage Strength
10 mg
Manufacturer
Sapphire Lifesciences Pvt. Ltd.
Importer
Nelpa Lifesciences, Inc.
Issuance Date
25 March 2021
Expiry Date
25 March 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a3b9243031a38889
Type
Standard
Back to Philippines FDA Approvals
Lorasaph - Philippines FDA Drug Approval Details